Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs lobectomy

References

• Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab. 1980;50:1089–1093.
   PubMed Web of Science ®Google Scholar
• Bransom CJ, Talbot CH, Henry L, et al. Solitary toxic adenoma of the thyroid gland. Br J Surg. 1979;66:592–595.
   PubMed Web of Science ®Google Scholar
• Eyre-Brook IA, Talbot CH. The treatment of autonomous functioning thyroid nodules. Br J Surg. 1982;69:577–579.
   PubMed Web of Science ®Google Scholar
• Mariotti S, Martino E, Francesconi M, et al. Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule. Acta Endocrinol (Copenh). 1986;113:500–507.
   PubMedGoogle Scholar
• Bolusani H, Okosieme OE, Velagapudi M, et al. Determinants of long-term outcome after radioiodine therapy for solitary autonomous thyroid nodules. Endocr Pract. 2008;14:543–549.
   PubMedGoogle Scholar
• Chianelli M, Bizzarri G, Todino V, et al. Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metab. 2014;99:E1283–E1286.
   PubMed Web of Science ®Google Scholar
• Watt T, Groenvold M, Rasmussen AK, et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol. 2006;154:501–510.
   PubMed Web of Science ®Google Scholar
• Watt T, Cramon P, Hegedüs L, et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab. 2014;99:3708–3717.
   PubMed Web of Science ®Google Scholar
• Cramon P, Winther KH, Watt T, et al. Quality-of-life impairments persist six months after treatment of graves' hyperthyroidism and toxic nodular goiter: a prospective cohort study. Thyroid. 2016;26:1010–1018.
   PubMedGoogle Scholar
• Shin YW, Choi YM, Kim HS, et al. Diminished quality of life and increased brain functional connectivity in patients with hypothyroidism after total thyroidectomy. Thyroid. 2016;26:641–649.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000;217:673–677.
   PubMed Web of Science ®Google Scholar
• Papini E, Rago T, Gambelunghe G, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules: results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014;99:3653–3659.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100:3903–3910.
   PubMed Web of Science ®Google Scholar
• Døssing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007;157:95–100.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Stacul F, Michelli A, et al. 12-Month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017;57:402–408.
   PubMed Web of Science ®Google Scholar
• Cesareo R, Naciu AM, Iozzino M, et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. Int J Hyperthermia. 2018;34:617–623.
   PubMed Web of Science ®Google Scholar
• Gambelunghe G, Stefanetti E, Colella R, et al. A single session of laser ablation for toxic thyroid nodules: three-year follow-up results. Int J Hyperthermia. 2018;34:631–635.
   PubMed Web of Science ®Google Scholar
• Amabile G, Rotondi M, Pirali B, et al. Interstitial laser photocoagulation for benign thyroid nodules: time to treat large nodules. Lasers Surg Med. 2011;43:797–803.
   PubMed Web of Science ®Google Scholar
• Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21:887–896.
   PubMed Web of Science ®Google Scholar
• Mishra A, Sabaretnam M, Chand G, et al. Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg. 2013;37:2322–2329.
   PubMed Web of Science ®Google Scholar
• Cramon P, Bonnema SJ, Bjorner JB, et al. Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population. Thyroid. 2015;25:284–291.
   PubMed Web of Science ®Google Scholar
• Yue WW, Wang SR, Li XL, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep. 2016;6:37838.
   PubMed Web of Science ®Google Scholar
• Gulseren S, Gulseren L, Hekimsoy Z, et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006;37:133–139.
   PubMed Web of Science ®Google Scholar
• Abraham-Nordling M, Törring O, Hamberger B, et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005;15:1279–1286.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Dobrinja C, Carere A, et al. Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia. 2018 [Aug 15]:[1–9]. doi:10.1080/02656736.2018.1487590
   PubMed Web of Science ®Google Scholar
• Pacella CM, Mauri G. Is there a role for minimally invasive thermal ablations in the treatment of autonomously functioning thyroid nodules? Int J Hyperthermia. 2018;34:636–638.
   PubMed Web of Science ®Google Scholar